Patent(s) and the Corresponding Patented Drug(s) |
Top |
United States Patent and Trademark Office (USPTO) |
Patent ID |
US9655879 |
Title |
Heteroarylcarboxylic acid ester derivative |
Abstract |
Compounds represented by the following formula (I); wherein each symbol is as defined in the specification, are useful as hyperglycemic inhibitors having a serine protease inhibitory action and as prophylactic or therapeutic drugs for diabetes. |
Applicant(s) |
EA Pharma Co., Ltd. |
Representative Drug(s) |
D0ZN0D |
Drug Info
|
N.A. |
Click to Show More |
[1] |
2
|
D0K3IO
|
Drug Info
|
N.A.
|
[1] |
Patent ID |
US9655879 |
Title |
Heteroarylcarboxylic acid ester derivative |
Abstract |
Compounds represented by the following formula (I); wherein each symbol is as defined in the specification, are useful as hyperglycemic inhibitors having a serine protease inhibitory action and as prophylactic or therapeutic drugs for diabetes. |
Applicant(s) |
EA Pharma Co., Ltd. |
Representative Drug(s) |
D0ZN0D |
Drug Info
|
N.A. |
Click to Show More |
[1] |
2
|
D0K3IO
|
Drug Info
|
N.A.
|
[1] |
Patent ID |
US9346821 |
Title |
Heterocyclic carboxylic acid ester derivative |
Abstract |
The present invention provides a blood glucose elevation inhibitor having a serine protease inhibitory action, which is a novel therapeutic or prophylactic agent for obesity. A compound represented by the following formula (I) wherein each symbol is as described in the specification, or a pharmaceutically acceptable salt thereof. |
Applicant(s) |
AJINOMOTO CO., INC. |
Representative Drug(s) |
D03SHV |
Drug Info
|
N.A. |
Click to Show More |
[2] |
2
|
D09KTX
|
Drug Info
|
N.A.
|
[2] |
3
|
D09VFP
|
Drug Info
|
N.A.
|
[2] |
Patent ID |
US9346821 |
Title |
Heterocyclic carboxylic acid ester derivative |
Abstract |
The present invention provides a blood glucose elevation inhibitor having a serine protease inhibitory action, which is a novel therapeutic or prophylactic agent for obesity. A compound represented by the following formula (I) wherein each symbol is as described in the specification, or a pharmaceutically acceptable salt thereof. |
Applicant(s) |
AJINOMOTO CO., INC. |
Representative Drug(s) |
D03SHV |
Drug Info
|
N.A. |
Click to Show More |
[2] |
2
|
D09KTX
|
Drug Info
|
N.A.
|
[2] |
3
|
D09VFP
|
Drug Info
|
N.A.
|
[2] |
Patent ID |
US9346821 |
Title |
Heterocyclic carboxylic acid ester derivative |
Abstract |
The present invention provides a blood glucose elevation inhibitor having a serine protease inhibitory action, which is a novel therapeutic or prophylactic agent for obesity. A compound represented by the following formula (I) wherein each symbol is as described in the specification, or a pharmaceutically acceptable salt thereof. |
Applicant(s) |
AJINOMOTO CO., INC. |
Representative Drug(s) |
D03SHV |
Drug Info
|
N.A. |
Click to Show More |
[2] |
2
|
D09KTX
|
Drug Info
|
N.A.
|
[2] |
3
|
D09VFP
|
Drug Info
|
N.A.
|
[2] |
Patent ID |
US9227949 |
Title |
Heteroarylcarboxylic acid ester derivative |
Abstract |
Compounds represented by the following formula (I); wherein each symbol is as defined in the specification,are useful as hyperglycemic inhibitors having a serine protease inhibitory action and as prophylactic or therapeutic drugs for diabetes. |
Applicant(s) |
AJINOMOTO CO., INC. |
Representative Drug(s) |
D0W6MZ |
Drug Info
|
N.A. |
[3] |
Patent ID |
US9024044 |
Title |
Heteroarylcarboxylic acid ester derivative |
Abstract |
Compounds represented by the following formula (I), are useful as hyperglycemic inhibitors having a serine protease inhibitory action and as prophylactic or therapeutic drugs for diabetes. |
Applicant(s) |
Ajinomoto Co., Inc. |
Representative Drug(s) |
D0VE7D |
Drug Info
|
N.A. |
Click to Show More |
[4] |
2
|
D01MPC
|
Drug Info
|
N.A.
|
[4] |
Patent ID |
US9024044 |
Title |
Heteroarylcarboxylic acid ester derivative |
Abstract |
Compounds represented by the following formula (I), are useful as hyperglycemic inhibitors having a serine protease inhibitory action and as prophylactic or therapeutic drugs for diabetes. |
Applicant(s) |
Ajinomoto Co., Inc. |
Representative Drug(s) |
D0VE7D |
Drug Info
|
N.A. |
Click to Show More |
[4] |
2
|
D01MPC
|
Drug Info
|
N.A.
|
[4] |
Patent ID |
US8609715 |
Title |
Heteroarylcarboxylic acid ester derivative |
Abstract |
Compounds represented by formula (I): wherein each symbol is as defined in the description, and pharmaceutically acceptable salts thereof are useful as hyperglycemic inhibitors having a serine protease inhibitory action and as prophylactic or therapeutic drugs for diabetes. |
Applicant(s) |
Ajinomoto Co., Inc. |
Representative Drug(s) |
D0G4ZU |
Drug Info
|
N.A. |
Click to Show More |
[5] |
2
|
D0L8BY
|
Drug Info
|
N.A.
|
[5] |
3
|
D0G2TL
|
Drug Info
|
N.A.
|
[5] |
Patent ID |
US8609715 |
Title |
Heteroarylcarboxylic acid ester derivative |
Abstract |
Compounds represented by formula (I): wherein each symbol is as defined in the description, and pharmaceutically acceptable salts thereof are useful as hyperglycemic inhibitors having a serine protease inhibitory action and as prophylactic or therapeutic drugs for diabetes. |
Applicant(s) |
Ajinomoto Co., Inc. |
Representative Drug(s) |
D0G4ZU |
Drug Info
|
N.A. |
Click to Show More |
[5] |
2
|
D0L8BY
|
Drug Info
|
N.A.
|
[5] |
3
|
D0G2TL
|
Drug Info
|
N.A.
|
[5] |
Patent ID |
US8609715 |
Title |
Heteroarylcarboxylic acid ester derivative |
Abstract |
Compounds represented by formula (I): wherein each symbol is as defined in the description, and pharmaceutically acceptable salts thereof are useful as hyperglycemic inhibitors having a serine protease inhibitory action and as prophylactic or therapeutic drugs for diabetes. |
Applicant(s) |
Ajinomoto Co., Inc. |
Representative Drug(s) |
D0G4ZU |
Drug Info
|
N.A. |
Click to Show More |
[5] |
2
|
D0L8BY
|
Drug Info
|
N.A.
|
[5] |
3
|
D0G2TL
|
Drug Info
|
N.A.
|
[5] |